La présente étude a permis, non seulement de mieux connaître les différents acteurs
de la ville de Cotonou sur la thématique du handicap, mais également de mettre en lumière
les actions qu’ils mènent. La problématique du handicap est mal connue dans la ville de
Cotonou : pas de statist...iques fiables (le dernier recensement national fait état de 2,55% de
personnes handicapées au sein la population nationale). Cependant, plus de 180
associations de personnes handicapées sont recensées sur le territoire national. Et bien que
le bénin soit signataire de nombreuses conventions et accords internationaux sur la
protection et la promotion des droits des personnes handicapées, il n’existe pas de
législation nationale spécifique, relative aux personnes handicapées. Il y a (trop !) peu de
campagnes officielles de sensibilisation sur les causes et la prévention du handicap, et les
commémorations conventionnelles passent souvent inaperçues. L’étude a permis de jeter
un regard sur les relations qu’ entretiennent les acteurs publics et associatifs entre eux.
more
Gestion de la Pharmacie dans les Centres de Santé au niveau périphérique
The aim of the operational framework is to ensure 1) accurate collection, handling, shipment and storage of specimens collected in countries implementing HIV drug resistance surveillance; and 2) the availability of quality-assured HIV genotyping laboratory services producing comparable and reliable ...results at the national, regional and global levels.
This publication updates the WHO HIVResNet HIV drug resistance laboratory operational framework published in 2017 and reflects technical and strategic developments over the past three years.
more
WHO recommends that pre-exposure prophylaxis (PrEP) be offered as an additional prevention choice for HIV-negative individuals at substantial risk of HIV infection as part of combination prevention approaches.
HIV drug resistance has been rarely reported among PrEP users who tested HIV positive i...n randomized controlled trials or open-label studies. However, PrEP-selected HIV drug resistance could potentially negatively impact the effectiveness of treatment options among PrEP users who acquire HIV, since there is a potential for overlapping resistance profiles between antiretroviral drugs used for both PrEP and first-line antiretroviral therapy.
more
Guidelines
June 2017
HIV strategic information for impact
WHO working group on HIV incidence assays meeting report
10–11 December 2015
Glion, Switzerland
UNAIDS/WHO working group on global HIV/AIDS and STI surveillance
WHO/HIV/2017.03
HIV patient monitoring and case surveillance
Information Note
Advice for countries using or planning
to introduce dual HIV/syphilis RDT in antenatal services and other testing sites.
WHO/RHR/17.01
Unite for Children
First Edition
Recommended actions at international and national levels
A practical toolkit for young people who are passionate about advancing HIV and sexual and reproductive health and rights through national advocacy in the post-2015 agenda.
UNAIDS 2018 / Guidance
Guidance for policy-makers, and people living with, at risk of or affected by HIV
UNAIDS 2017 / Reference
Generating evidence for policy and action on HIV and social protection
Translating Community Research Into Global Policy Reform For National Action: A Checklist For Community Engagement To Implement The WHO Consolidated Guideline On The Sexual And Reproductive Health And Rights Of Women Living With HIV
3rd edition | December 2018